Variant report
Variant | nsv527135 |
---|---|
Chromosome Location | chr2:52957024-53019822 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ASB3-1 | chr2:52959880-52959915 | ENSG00000228033 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs530846924 | chr2:52959805-52959806 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs34442299 | chr2:52959843-52959844 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs550860150 | chr2:52959873-52959874 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs564540089 | chr2:52959920-52959921 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs533152669 | chr2:52959927-52959928 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs145263050 | chr2:52959934-52959935 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs566845529 | chr2:52959944-52959945 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs546995857 | chr2:52959948-52959949 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs190531667 | chr2:52959971-52959972 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs1843039 | chr2:52959983-52959984 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs536138364 | chr2:52960004-52960005 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs569083610 | chr2:52960018-52960019 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs538179539 | chr2:52960069-52960070 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs567992242 | chr2:52960075-52960076 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs558144566 | chr2:52960085-52960086 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs576815840 | chr2:52960099-52960100 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs182961945 | chr2:52960114-52960115 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs188799125 | chr2:52960149-52960150 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs192696414 | chr2:52960164-52960165 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs147687663 | chr2:52960173-52960174 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs142456392 | chr2:52960202-52960203 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs13401973 | chr2:52960203-52960204 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs371977067 | chr2:52960206-52960207 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs575496396 | chr2:52960222-52960223 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs114246426 | chr2:52960237-52960238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs149761216 | chr2:52960260-52960261 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs533407690 | chr2:52960284-52960285 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs2603423 | chr2:52960298-52960299 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs7592488 | chr2:52960329-52960330 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs529371699 | chr2:52960367-52960368 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs113532836 | chr2:52960472-52960473 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs549048454 | chr2:52960482-52960483 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs145710994 | chr2:52960484-52960485 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs183284938 | chr2:52960519-52960520 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs373143962 | chr2:52960571-52960572 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs148941476 | chr2:52960574-52960575 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs545519237 | chr2:52960619-52960620 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs7592833 | chr2:52960639-52960640 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs552714821 | chr2:52960641-52960642 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs566440316 | chr2:52960703-52960704 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs2626390 | chr2:52960727-52960728 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs187456703 | chr2:52960745-52960746 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs191336800 | chr2:52960748-52960749 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs544067448 | chr2:52960766-52960767 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs375728655 | chr2:52960794-52960795 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs547449539 | chr2:52960885-52960886 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs561787203 | chr2:52960887-52960888 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs557896772 | chr2:52960950-52960951 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs73931435 | chr2:52960964-52960965 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs540493998 | chr2:52960993-52960994 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:52959800-52960600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
2 | chr2:52959800-52961200 | Enhancers | Stomach Mucosa | stomach |
3 | chr2:52960000-52960400 | Enhancers | H1 Cell Line | embryonic stem cell |
4 | chr2:52960000-52960400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
5 | chr2:52960000-52960400 | Enhancers | Spleen | Spleen |
6 | chr2:52960000-52960600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
7 | chr2:52960000-52960600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
8 | chr2:52960200-52960600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
9 | chr2:52960200-52960600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
10 | chr2:52960600-52961600 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
11 | chr2:52961200-52961600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr2:52961600-52961800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
13 | chr2:52968200-52968800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
14 | chr2:52972800-52973400 | Active TSS | Fetal Heart | heart |
15 | chr2:53003600-53004200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
16 | chr2:53003800-53004200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
17 | chr2:53004200-53006400 | Enhancers | Fetal Intestine Large | intestine |